Literature DB >> 24876938

Extent of lymph node dissection: common hepatic artery lymph node dissection can be omitted for esophageal squamous cell carcinoma.

Xiao Ma1, Bin Li1, Su Yang1, Wei Guo1, Xiaoli Zhu1, Hecheng Li1, Jiaqing Xiang1, Yawei Zhang1, Haiquan Chen1.   

Abstract

OBJECTIVES: Controversy persists regarding the adequate extent of lymph node (LN) dissection in thoracic esophageal cancer (EC) surgery. Oncologic efficacy should be balanced with the increased risk of postoperative complications after aggressive radical LN dissection. Here, we evaluate the effectiveness of common hepatic artery LN dissection in surgery for thoracic esophageal squamous cell carcinoma. PATIENTS AND METHODS: Among a total of 1,563 EC patients who underwent surgery from May 2005 to December 2012 at the Fudan University Shanghai Cancer Center, 1,248 thoracic esophageal squamous cell carcinoma were selected for this study, including 682 patients who underwent esophagectomy with common hepatic artery LN dissection and 566 patients who underwent esophagectomy without common hepatic artery LN dissection. The clinical data of patients were retrospectively analyzed. In addition, the locoregional LN metastasis, relationship between metastatic rates of common hepatic artery LN and clinicopathological factors were analyzed. A propensity score match analysis were performed to control for potential differences in the characteristics of patients with EC cell carcinoma, and postoperative complications were analyzed after propensity score-matching.
RESULTS: The metastatic rate of common hepatic LN was 3.5%. Logistic regression analysis revealed tumor diameter, N classification and pTNM stage were risk factors for common hepatic LN metastasis. Matching based on propensity scores produced 361 patients in each group. The overall incidence of postoperative complications was 32.70% and 35.45%, respectively, no significant difference was found (P=0.432).
CONCLUSIONS: The metastatic rate of common hepatic artery LN is low. For patients who undergo resection for Stage I thoracic esophageal squamous cell carcinoma, the dissection of common hepatic artery LN may be safely omitted.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; common hepatic artery lymph node (common hepatic artery LN); lymph node dissection (LN dissection); propensity score match

Year:  2014        PMID: 24876938      PMCID: PMC4037418          DOI: 10.3978/j.issn.2072-1439.2014.04.33

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy?

Authors:  T W Rice
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

2.  The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma: does lymph node yield matter?

Authors:  H Li; S Yang; J Xiang; H Chen
Journal:  Dis Esophagus       Date:  2010-09-02       Impact factor: 3.429

Review 3.  Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.

Authors:  B Kayani; E Zacharakis; K Ahmed; G B Hanna
Journal:  Eur J Surg Oncol       Date:  2011-09       Impact factor: 4.424

4.  Chylous ascites in a patient with esophageal carcinoma.

Authors:  Kwok Kay Yau; Wing Tai Siu; Michael Ka Wah Li
Journal:  Clin Gastroenterol Hepatol       Date:  2005-09       Impact factor: 11.382

5.  Lymph flow and lymph node metastasis in esophageal cancer.

Authors:  T Nishihira; J Sayama; H Ueda; K Sugawara; R Takano; J Sagawa; M Katayama; R Shineha; K Hirayama; S Mori
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  Lymph node metastases in cancer of the thoracic esophagus.

Authors:  Y Sannohe; R Hiratsuka; K Doki
Journal:  Am J Surg       Date:  1981-02       Impact factor: 2.565

8.  The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.

Authors:  H-L Zhang; L-Q Chen; R-L Liu; Y-T Shi; M He; X-L Meng; S-X Bai; Y-M Ping
Journal:  Dis Esophagus       Date:  2009-04-15       Impact factor: 3.429

9.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

10.  Abdominal lymph node metastasis in patients with mid thoracic esophageal squamous cell carcinoma.

Authors:  Gang Chen; Zhou Wang; Xiang-yan Liu; Ming-yue Zhang; Fan-ying Liu
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

View more
  2 in total

1.  Supraclavicular and celiac metastases in squamous cell carcinoma of the middle thoracic esophagus.

Authors:  Akihiko Okamura; Masayuki Watanabe; Ryotaro Kozuki; Tasuku Toihata; Masami Yuda; Yu Imamura; Shinji Mine
Journal:  Langenbecks Arch Surg       Date:  2018-10-25       Impact factor: 3.445

2.  Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma.

Authors:  Xue Li; Lujun Zhao; Wencheng Zhang; Chengwen Yang; Zhen Lian; Shuai Wang; Ningbo Liu; Qingsong Pang; Ping Wang; Jinming Yu
Journal:  Oncotarget       Date:  2017-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.